Nishina T - Search Results

1

[A case of advanced colon cancer with metastases to both supraclavicular and para-aortic lymph nodes effectively treated by radiation and S-1 therapy].

Sasaki Y, Kunieda K, Imai T, Sakuratani T, Tajima JY, Kanematsu M, Yamada A, Matsuhashi N, Tanaka C, Nishina T, Nagao N, Kawai M, Furuichi N, Yanagawa S. Sasaki Y, et al. Among authors: nishina t. Gan To Kagaku Ryoho. 2010 Dec;37(13):2929-31. Gan To Kagaku Ryoho. 2010. PMID: 21160273 Japanese.

2

[Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection].

Tanaka C, Kunieda K, Kawai M, Nagao N, Nishina T, Matsuhashi N, Sasaki Y, Yamada A, Kanematsu M, Imai T, Sakuratani T, Tajima JY. Tanaka C, et al. Among authors: nishina t. Gan To Kagaku Ryoho. 2010 Jun;37(6):1105-9. Gan To Kagaku Ryoho. 2010. PMID: 20567117 Japanese.

3

A patient with spontaneous rupture of the esophagus and concomitant gastric cancer whose life was saved: case of report and review of the literature in Japan.

Matsuhashi N, Nagao N, Tanaka C, Nishina T, Kawai M, Kunieda K, Iwata H. Matsuhashi N, et al. Among authors: nishina t. World J Surg Oncol. 2011 Dec 6;9:161. doi: 10.1186/1477-7819-9-161. World J Surg Oncol. 2011. PMID: 22145619 Free PMC article. Review.

4

[A case of secondary leukemia induced by chemotherapy with a CDDP-based regimen for gastric cancer 5 years following radical resection].

Kato M, Saji S, Furuta T, Tanemura H, Azuma S, Nishina T, Kuno T, Takahashi K. Kato M, et al. Among authors: nishina t. Gan To Kagaku Ryoho. 1993 Jan;20(1):137-40. Gan To Kagaku Ryoho. 1993. PMID: 8422178 Japanese.

5

Establishing an Indicator of Hypokalemia in Patients Receiving Anti-Epidermal Growth Factor Receptor Antibodies.

Yasuda M, Tachi T, Umeda M, Osawa T, Makino T, Nagaya K, Koda A, Setta E, Matsui K, Nishina T, Yamada M, Goto C, Teramachi H. Yasuda M, et al. Among authors: nishina t. Gan To Kagaku Ryoho. 2016 Mar;43(3):335-9. Gan To Kagaku Ryoho. 2016. PMID: 27067850

6

Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial.

Imai M, Nakamura Y, Shin S, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Sawada K, Sato A, Kuwata T, Yamashita R, Fujisawa T, Bando H, Ock CY, Fujii S, Yoshino T. Imai M, et al. Among authors: nishina t. JCO Precis Oncol. 2025 Jan;9:e2400385. doi: 10.1200/PO-24-00385. Epub 2025 Jan 17. JCO Precis Oncol. 2025. PMID: 39823559 Free PMC article. Clinical Trial.

7

Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.

Siena S, Raghav K, Masuishi T, Yamaguchi K, Nishina T, Elez E, Rodriguez J, Chau I, Di Bartolomeo M, Kawakami H, Suto F, Koga M, Inaki K, Kuwahara Y, Takehara I, Barrios D, Kobayashi K, Grothey A, Yoshino T. Siena S, et al. Among authors: nishina t. Nat Commun. 2025 Jan 15;16(1):704. doi: 10.1038/s41467-025-56170-9. Nat Commun. 2025. PMID: 39814812 Free PMC article. No abstract available.

8

Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.

Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, Schenker M, de la Fouchardiere C, Limon ML, Yoshino T, Li J, Lenz HJ, Manzano Mozo JL, Tortora G, Garcia-Carbonero R, Dahan L, Chalabi M, Joshi R, Goekkurt E, Braghiroli MI, Cil T, Cela E, Chen T, Lei M, Dixon M, Abdullaev S, Lonardi S; CheckMate 8HW Investigators. Andre T, et al. N Engl J Med. 2024 Nov 28;391(21):2014-2026. doi: 10.1056/NEJMoa2402141. N Engl J Med. 2024. PMID: 39602630 Clinical Trial.

9

Siena S, Raghav K, Masuishi T, Yamaguchi K, Nishina T, Elez E, Rodriguez J, Chau I, Di Bartolomeo M, Kawakami H, Suto F, Koga M, Inaki K, Kuwahara Y, Takehara I, Barrios D, Kobayashi K, Grothey A, Yoshino T. Siena S, et al. Among authors: nishina t. Nat Commun. 2024 Nov 25;15(1):10213. doi: 10.1038/s41467-024-53223-3. Nat Commun. 2024. PMID: 39587050 Free PMC article. Clinical Trial.

10

Authors' reply to 'RE: A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group'.

Nishina T, Boku N, Kurokawa Y, Sasaki K, Machida R, Yoshikawa T. Nishina T, et al. Jpn J Clin Oncol. 2025 Jan 8;55(1):89-90. doi: 10.1093/jjco/hyae149. Jpn J Clin Oncol. 2025. PMID: 39558684 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters